ARQT
NASDAQ · Biotechnology
Arcutis Biotherapeutics Inc
$25.55
-1.45 (-5.37%)
Performance
1D
+0.00%
1W
-18.27%
1M
+4.33%
3M
-1.43%
6M
+20.29%
1Y
+5.45%
YTD
-11.90%
Open$26.70
Previous Close$27.00
Day High$27.09
Day Low$25.29
52W High$34.80
52W Low$19.30
Volume—
Avg Volume2.45M
Market Cap3.22B
P/E Ratio113.00
EPS$0.21
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$27.16
Below
SMA 200
$25.34
Above
RSI (14)
31.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
13 analysts
Price Target
+235.7% upside
Current
$25.55
$25.55
Target
$85.78
$85.78
$74.20
$85.78 avg
$112.10
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 372.83M | 947.52M | 972.47M |
| Net Income | -16,006,495 | 179.95M | 161.28M |
| Profit Margin | -4.3% | 19.0% | 16.6% |
| EBITDA | -12,121,546 | 271.10M | 315.26M |
| Free Cash Flow | — | 104.36M | 84.89M |
| Rev Growth | +367.1% | -4.3% | +9.4% |
| Debt/Equity | 0.58 | 0.78 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |